Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
4
×
astrazeneca
4
×
biotech
boston blog main
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
4
×
wisconsin blog main
wisconsin top stories
amgen
boston top stories
cancer
novartis
allergan
biogen
celgene
clinical trials
covid-19
deals
duchenne muscular dystrophy
eli lilly
What
bio
roundup
acquisitions
ceo
daniel
gilead
opioid
o’day
sciences
abbvie’s
announced
august
barbecuing
biggest
biotech
build
busy
buy
camping
cardiologist
center
check
cholesterol
collabs
company’s
conference
covid
day
days
deal
debut
decisions
devices
drug
drugs
dyne’s
fda
flop
gilead’s
help
Language
unset
4
×
Current search:
abbvie
×
unset
×
astrazeneca
×
" texas top stories "
×
@xconomy.com
4 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
5 years ago
Bio Roundup: Cholesterol Check, J&J’s Opioid Hit, AbbVie’s Flop & More
@xconomy.com
5 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More